Genliang Lu

Genliang Lu has extensive experience in medicinal chemistry, holding positions from Research Scientist to Senior Director at various pharmaceutical companies. Their work includes designing and synthesizing clinical candidates for cancer treatment, as well as expanding drug conjugate platforms. Lu has contributed to the development of lead compounds for prostate cancer and TB treatment, showcasing a strong background in drug discovery and development.

Genliang Lu obtained a Master of Science degree in Organic Chemistry from Zhejiang University. Subsequently, they completed postdoctoral studies in Organic Chemistry at The University of Kansas and Texas A&M University. Finally, Genliang Lu attained a PhD in Organic Chemistry from South Dakota State University.